Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis.
Alba-Arbalat S, Solana E, Lopez-Soley E, Camos-Carreras A, Martinez-Heras E, Vivó F, Pulido-Valdeolivas I, Andorra M, Sepulveda M, Cabrera JM, Fonseca E, Calvi A, Alcubierre R, Dotti-Boada M, Saiz A, Martinez-Lapiscina EH, Villoslada P, Blanco Y, Sanchez-Dalmau B, Llufriu S. Alba-Arbalat S, et al. Among authors: calvi a. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):419-425. doi: 10.1136/jnnp-2023-332332. J Neurol Neurosurg Psychiatry. 2024. PMID: 37989566
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes.
Martinez-Heras E, Solana E, Vivó F, Lopez-Soley E, Calvi A, Alba-Arbalat S, Schoonheim MM, Strijbis EM, Vrenken H, Barkhof F, Rocca MA, Filippi M, Pagani E, Groppa S, Fleischer V, Dineen RA, Bellenberg B, Lukas C, Pareto D, Rovira A, Sastre-Garriga J, Collorone S, Prados F, Toosy A, Ciccarelli O, Saiz A, Blanco Y, Llufriu S. Martinez-Heras E, et al. Among authors: calvi a. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):916-923. doi: 10.1136/jnnp-2023-331531. Epub 2023 Jun 15. J Neurol Neurosurg Psychiatry. 2023. PMID: 37321841
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, Wright S, Shatila M, Yiannakas MC, Chowdhury F, Stutters J, Ricciardi A, Prados F, MacManus D, Braisher M, Blackstone J, Ciccarelli O, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; UCL MS-STAT2 investigators. Williams T, et al. Among authors: calvi a. Eur J Neurol. 2023 Sep;30(9):2769-2780. doi: 10.1111/ene.15924. Epub 2023 Jun 23. Eur J Neurol. 2023. PMID: 37318885 Clinical Trial.
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: calvi a. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.
Pietroboni AM, Scarioni M, Carandini T, Basilico P, Cadioli M, Giulietti G, Arighi A, Caprioli M, Serra L, Sina C, Fenoglio C, Ghezzi L, Fumagalli GG, De Riz MA, Calvi A, Triulzi F, Bozzali M, Scarpini E, Galimberti D. Pietroboni AM, et al. Among authors: calvi a. J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):352-357. doi: 10.1136/jnnp-2017-316603. Epub 2017 Oct 20. J Neurol Neurosurg Psychiatry. 2018. PMID: 29054920
114 results